Cargando…
Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically
Intensive cancer treatment with drug combination is widely exploited in the clinic but suffers from inconsistent pharmacokinetics among different therapeutic agents. To overcome it, the emerging nanomedicine offers an unparalleled opportunity for encapsulating multiple drugs in a nano-carrier. Herei...
Autores principales: | Gong, Liuyun, Lu, Yinliang, Wang, Jing, Li, Xinyue, Zhao, Jing, Chen, Yuetong, Ma, Rongze, Ma, Jinlu, Liu, Tianya, Han, Suxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334348/ https://www.ncbi.nlm.nih.gov/pubmed/37440910 http://dx.doi.org/10.1016/j.jpha.2023.04.017 |
Ejemplares similares
-
Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer
por: Tan, Xinyue, et al.
Publicado: (2020) -
Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
por: Long, Huideng, et al.
Publicado: (2023) -
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022) -
Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway
por: Gong, Liuyun, et al.
Publicado: (2020) -
CRISPR-based screening identifies XPO7 as a positive regulator of senescence
por: Li, Lan-Zhu, et al.
Publicado: (2023)